Cure for cancer arrives in a year, say Israeli scientists

An Israeli pharmaceutical company is claiming it will have “a complete cure for cancer” within a year. The news rekindles hope for a cure for an ailment that has plagued humanity for so long, but seems too good to be true. Will the promise come true?

Israelis against cancer

The company behind this bold news is Accelerated Evolution Biotechnologies (AEBi), and based on the allegations of its chairman of the board Dan Aridor, the treatment you're working on sounds revolutionary.

“Our cancer cure will be effective from day one, last a few weeks, and have minimal or minimal side effects at a much lower cost than most other treatments on the market,” Aridor told the press. “Our solution will be generic and personal.”

According to information, the AEBi cancer cure is called mutato, which stands for “multi-targeted toxin”. It attacks cancer cells with several peptides – made up of chains of amino acids – at once, and this multifaceted attack is key to the treatment's effectiveness.

“We guarantee that the treatment will not be affected by mutations; Cancer cells can mutate in such a way that the target receptors are eliminated by the cancer,” he said. Ilan Morad, CEO of AEBi. “The probability of having multiple mutations that would modify all target receptors simultaneously decreases dramatically with the number of targets used.”

“Instead of attacking receivers one at a time, we attack receivers three at a time,” he continued. "Not even cancer can mutate three receptors at the same time."

A future without cancer?

Morad claims in the Post that AEBi used its cancer treatment to inhibit the growth of human cancer cells in mice without affecting the animals' healthy cells.

The company has also completed several in vitro tests and will soon begin clinical trials, according to Morad. They could be gone within a few years, said the CEO of AEBi, after which treatment may be available in specific cases.

That's a lot of claims, but the original article in which the news was published doesn't mention the existence of any peer-reviewed research that might support them.

Clearly, the kind of treatment that scientists Israelis are proposing would be extraordinary – after all, the cancer is the second most common cause of death worldwide. But let's reserve our excitement until this pharmaceutical company's cancer cure stands up to the scrutiny of the scientific community.